PKM2 Expression as Biomarker for Resistance to Oxaliplatin-Based Chemotherapy in Colorectal Cancer

The purpose of the current study is to investigate the prognostic significance of M2 isoform of pyruvate kinase (PKM2) mRNA expression loss in patients with operable colon cancer (CC). Two hundred sixty-two specimens from patients with stage-III or high-risk stage-II CC (group-A) treated with adjuva...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancers (Basel)
Prif Awduron: Sfakianaki, Maria, Papadaki, Chara, Tzardi, Maria, Trypaki, Maria, Manolakou, Stavroula, Messaritakis, Ippokratis, Saridaki, Zenia, Athanasakis, Elias, Mavroudis, Dimitrios, Tsiaoussis, John, Gouvas, Nikolaos, Souglakos, John
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI 2020
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7465271/
https://ncbi.nlm.nih.gov/pubmed/32722474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12082058
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg